Parmar A, Gupta P, Panda U, Bhad R. An observational study assessing the pathways to care among treatment-seeking users of natural opiates. Drugs 2020;27:199–204. DOI: 10.1080/09687637.2019.1649363.
Malviya A, Negi N, Mandora M, Yadav JK. Perioperative status and complications in opium addicts in Western Rajasthan. Indian J Surg 2011;73:346–351. DOI: 10.1007/s12262-011-0324-4.
Meader N. A comparison of methadone, buprenorphine and alpha2 adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis. Drug Alcohol Depend 2010;108:110–114. DOI: 10.1016/j.drugalcdep.2009.12.008.
Gowing L, Ali R, White JM, Mbewe D. Buprenorphine for managing opioid withdrawal. Cochrane Database Syst Rev 2017;2:CD002025. DOI: 10.1002/14651858.CD002025.pub5.
Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med 2000;343:1290–1297. DOI: 10.1056/NEJM200011023431802.
Mitchell TB, White JM, Somogyi AA, Bochner F. Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence. Drug Alcohol Depend 2003;72:85–94. DOI: 10.1016/s0376-8716(03)00190-x.
Jittiwutikarn J, Ali R, White JM, Bochner F, Somogyi AA, Foster DJ. Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre. Br J Clin Pharmacol 2004;58:536–541. DOI: 10.1111/j.1365-2125.2004.02209.x
Wesson DR, Ling W. The clinical opiate withdrawal scale (COWS). J Psychoactive Drugs 2003;35:253–259. DOI: 10.1080/02791072.2003.10400007.
Gowing L, Ali R, White JM. Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev 2009;3:CD002025. DOI: 10.1002/14651858.CD002025.pub4.
Ananda RA, Attwood LO, Lancaster R, Jacka D, Jhoomun T, Danks A, et al. The clinical and financial burden of spinal infections in people who inject drugs. Intern Med J 2021. DOI: 10.1111/imj.15397.
Hall W, Stjepanović D, Caulkins J, Lynskey M, Leung J, Campbell G, et al. Public health implications of legalising the production and sale of cannabis for medicinal and recreational use. Lancet 2019;394:1580–1590. DOI: 10.1016/S0140-6736(19)31789-1.
Sahu KK, Mishra A, Naraghi L. Erythema ab igne as a complication of cannabinoid hyperemesis syndrome. BMJ Case Rep 2019;12:e227836. DOI: 10.1136/bcr-2018-227836.
Sahu KK, Tsitsilianos N, Mishra AK, Suramaethakul N, Abraham G. Neck abscess secondary to pocket shot intravenous drug abuse. BMJ Case Rep 2020;13:e234033. DOI: 10.1136/bcr-2019-234033.
